Cargando…

Hydroxychloroquine and azithromycin as potential treatments for COVID-19; clinical status impacts the outcome

Detalles Bibliográficos
Autores principales:	Okour, Malek, Al-Kofahi, Mahmoud, Austin, Daren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220612/ https://www.ncbi.nlm.nih.gov/pubmed/32405664 http://dx.doi.org/10.1007/s10928-020-09689-x

Ejemplares similares

Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin
por: Million, Matthieu, et al.
Publicado: (2021)

Hydroxychloroquine and azithromycin as a treatment of COVID-19
por: Fanin, Alice, et al.
Publicado: (2020)

Hydroxychloroquine + azithromycin treatment in elderly patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Impact of Azithromycin and/or Hydroxychloroquine on Hospital Mortality in COVID-19
por: Albani, Filippo, et al.
Publicado: (2020)

Intracellular ABCB1 as a Possible Mechanism to Explain the Synergistic Effect of Hydroxychloroquine-Azithromycin Combination in COVID-19 Therapy
por: Scherrmann, JM.
Publicado: (2020)

Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
por: Arshad, Samia, et al.
Publicado: (2020)

Lessons learnt from hydroxychloroquine/azithromycin in treatment of COVID-19
por: Xu, Jiuyang, et al.
Publicado: (2022)

Hydroxychloroquine and Azithromycin as a Treatment of COVID-19: Electrocardiogram Variability
por: EL Ouarradi, Amal, et al.
Publicado: (2020)

Hydroxychloroquine-azithromycin for COVID-19 – Warranted or dangerous?
por: Popescu, Corneliu P., et al.
Publicado: (2020)

Environmental impacts of COVID-19 treatment: Toxicological evaluation of azithromycin and hydroxychloroquine in adult zebrafish
por: Mendonça-Gomes, Juliana Moreira, et al.
Publicado: (2021)

Hydroxychloroquine- and azithromycin-related heart disorders
Publicado: (2020)

Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)

Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19
por: Gautret, Philippe, et al.
Publicado: (2021)

Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Treatment of COVID-19 in pregnancy with hydroxychloroquine and azithromycin: a case report
por: Sisti, Giovanni, et al.
Publicado: (2020)

No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France”
por: Lebeaux, David, et al.
Publicado: (2020)

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
por: Cavalcanti, Alexandre B., et al.
Publicado: (2020)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin
por: Derendorf, Hartmut
Publicado: (2020)

Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19
por: Hennekens, Charles H., et al.
Publicado: (2022)

Focus on clinical outcomes of “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”
por: Wambier, Carlos Gustavo
Publicado: (2021)

Problems with the analysis in “Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19”
por: Atkinson, J. Graham
Publicado: (2020)

Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
por: Bakadia, Bianza Moise, et al.
Publicado: (2021)

THE EFFECT OF TREATMENT WITH HYDROXYCHLOROQUINE AND AZITHROMYCIN ON THE CORRECTED QT INTERVAL IN PATIENTS WITH COVID-19
por: Batemarco, Thomas, et al.
Publicado: (2022)

Conflicting evidence on the efficacy of hydroxychloroquine and azithromycin as the early treatment of COVID-19. Comment on “Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France”
por: Bonny, Aimé, et al.
Publicado: (2020)

Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia
por: Mori, Nobuaki, et al.
Publicado: (2021)

Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients
por: Alizargar, Javad
Publicado: (2020)

Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19
por: Lamback, Elisa Baranski, et al.
Publicado: (2021)

Use of hydroxychloroquine and azithromycin combination to treat the COVID-19 infection
por: Bajpai, Jyoti, et al.
Publicado: (2022)

Cardiovascular Safety of Hydroxychloroquine–Azithromycin in 424 COVID-19 Patients
por: Million, Matthieu, et al.
Publicado: (2023)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2020)

Anticoagulants/azithromycin/hydroxychloroquine: Spontaneous haematoma: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: Prolongation of the QT interval: case report
Publicado: (2020)

Azithromycin/ceftriaxone/hydroxychloroquine: Acute urticaria: case report
Publicado: (2020)

Azithromycin/hydroxychloroquine: SDRIFE-like rash: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: QTc interval prolongation: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Lack of efficacy: 2 case reports
Publicado: (2022)

Azithromycin/hydroxychloroquine/methylprednisolone: Various toxicities: case report
Publicado: (2021)

Azithromycin/hydroxychloroquine: Various toxicities: 4 case reports
Publicado: (2021)

Azithromycin/hydroxychloroquine/methylprednisolone: Various toxicities: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5e7vfrjm0p3sri5kg03fojg7hb